Waldencast plc
corporate_fare Company Profile
Waldencast plc (NASDAQ:WALD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for WALD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 9/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for WALD spans 6-K, 4, SCHEDULE 13D/A, 20-F.
Recent high-impact activity:
- Waldencast to Voluntarily Delist from Nasdaq and Deregister — Last Trading Day Expected October 2
- Director and 10% Owner Cristiano Souza Buys $505K of Waldencast Shares
- Waldencast Finalizes Obagi Sale, Unveils Post-Transaction Financials and Leadership Reshuffle
- Major Investor Liquidates Entire 7.5% Stake in Waldencast plc
- FDA Approves Obagi Medical's saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Financial Snapshot
Insider Transactions
WALD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.